TrialBMC pulmonary medicine2024

Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study.

Masato Karayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.